WENDY PEARCE: Open Payments
NPI 1073968574 · CAIRO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 25 payments from 11 companies in 2025. Trend: 2023 $268 · 2024 $507 · 2025 $707
Food & beverage: $707
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $180 |
| Corcept Therapeutics | 3 | $154 |
| Novo Nordisk Inc | 4 | $84 |
| QOL Medical, LLC | 2 | $74 |
| Exact Sciences Corporation | 2 | $52 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Lundbeck LLC | 1 | $27 |
| PFIZER INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $15 |
Products named: Korlym, VRAYLAR, Sucraid, Cologuard Collection Kit, Wegovy, Kerendia, QULIPTA, AIRSUPRA.
Industry payments across GA — which companies pay providers there.
